Accès direct au contenu


Version française > Publications > Publications 2012

Publications 2012


KHAMDUANG W
, GAUDY-GRAFFIN C, NGO-GIANGHUONG N, JOURDAIN G, MOREAU A, LUEKAMLUNG N, HALUE G, BURANAWANITCHAKORN Y, KUNKONGKAPAN S, BURANABANJASATEN S, LALLEMANT M, SIRIRUNGSI W, GOUDEAU A. Long-term hepatitits B virus (HBV) response to lamivudine-containing highly active antiretroviral therapy in HIV-HBV co-infected patients in Thailand. PLoS One 2012, 7(7) : e42184, Epub 2012 Jul 31.

CHAILLON A
, BRAIBANT M, HUE S, BENCHARIF S, ENARD D, MOREAU A, SAMRI A, AGUT H, BARIN F. Human immunodeficiency virus type-1 (HIV-1) continues to evolve in presence of broadly neutralizing antibodies more that ten years after infection. PLoS One 2012,7(8) : e44163, Epub 2012 Aug 30.


CHAILLON A
, WACK T, BRAIBANT M, MANDELBROT L, BLANCHE S, WARSZAWSKI J, BARIN F. The breadth and titer of maternal human immunodeficiency virus type 1 (HIV-1)-specific heterologous neutralizing antibodies are not associated with a lower rate of mother-to-child transmission of HIV-1. J Virol 2012, 86(19):10540-6.

LE VU S, VELTER A, MEYER L, PEYTAVIN G, GUINARD J, PILLONEL J, BARIN F, SEMAILLE C.Biomarker-based HIV incidence in a community sample of men who have sex with men in Paris, France. PLoS One 2012, 7, e39872.

ROINGEARD P. Quantifying hepatic steatosis by electron microscopy. Histopathology 2012, 61(5), 991-3.

BRAND D, CAZEIN F, LOT F, BRUNET S, THIERRY D, MOREAU A, PILLONEL J, SEMAILLE C, BARIN F. Continuous spread of HIV-1 subtypes D and CRF01_AE in France, 2003-2009. J Clin Microbiol 2012, 50, 2484-2488.

CAZEIN F, BARIN F, Le STRAT Y, PILLONEL J, Le VU S, LOT F, THIERRY D, MEFFRE C, SEMAILLE C. Prevalence and characteristics of individuals with undiagnosed HIV infection in France: evidence from a survey on hepatitis B and C seroprevalence. JAIDS 2012, 60, e116-118.

THENIN S, ROCH E, SAMLEERAT T, MOREAU T, CHAILLON A, MOREAU A, BARIN F, BRAIBANT M. Naturally occuring substitutions of conserved residues in HIV-1 variants of different clades are involved in PG9 and PG16 resistance to neutralization. J Gen Virol 2012, 93, 1495-1505.

DEPLA M, d’ALTEROCHE L, LE GOUGE A, MOREAU A, HOURIOUX C, MEUNIER JC, GAILLARD J, de MURET A, BACQ Y, KAZEMI F, AVARGUES A, ROCH E, PIVER E, GAUDY-GRAFFIN C, GIRAUDEAU B, ROINGEARD P. Viral sequence variation in chronic carriers of hepatitis C virus has low impact on liver steatosis. PloS One 2012, 7(3): e33749.

THENIN S, SAMLEERAT T, TAVERNIER E, NGO-GIANG-HUONG, JOURDAIN G, LALLEMANT M, BARIN F, BRAIBANT M. Envelope glycoproteins of human immunodeficiency virus type 1 variants issued from mother-infant pairs display a wide spectrum of biological properties. Virology 2012, 426, 12-21.

MONEL B, BEAUMONT E, VENDRAME D, SCHWARTZ O, BRAND D, MAMMANO F. HIV cell-to-cell transmission requires the production of infectious virus particles, and does not proceed through Env-mediated fusion pores. J Virol 2012, 86, 3924-3933.


  • Facebook
  • twitter
  • google
  • imprimer
  • version PDF
  • Envoyer cette page

English version 


Contact 


Inserm - U966 MAVIVH
10 boulevard Tonnellé - BP 3223
37032 Tours Cedex 1 - France
Tél. : 33 (2) 47 36 61 27
Fax : 33 (2) 47 36 61 26

Secrétariat :
E-mail : angelique.masse@univ-tours.fr

Directeur : Philippe ROINGEARD

E-mail : roingeard@med.univ-tours.fr

Directeur adjoint : Francis BARIN

E-mail : fbarin@med.univ-tours.fr

 

Retour au site institutionnel